Skip to content
Screener

Accrued Expenses at other companies

Abbott logo
AbbottABT
$1.62B-71.4%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$148.4M-5.7%
Danaher logo
DanaherDHR
$4.87B+6.7%
OraSure Technologies logo
OraSure TechnologiesOSUR
$8.14M
Revvity logo
RevvityRVTY
$10.6M-4.5%
Opko Health logo
Opko HealthOPK
$77.76M-14.1%

Other financials

Income statement

See full
Revenue$630.9M+2.8%
Gross profit$272.9M-0.7%
Operating income-$21.8M+87.9%
Net income-$92.9M+63.6%
EPS (diluted)-$1.36+63.9%

Balance sheet

See full
Cash & equivalents$123.4M-18.7%
Total debt$3.4B+3.0%
Total equity$1.8B-36.4%
Total assets$5.7B-10.4%

Cash flow

See full
Operating cash flow-$110.6M
CapEx$25.5M-32.0%
Free cash flow-$136.1M-61.4%

Valuation

See full
Market cap$942.91M-41.3%
Enterprise value$4.25B-11.2%
P/S0.4×-0.2×

Profitability

See full
Gross margin44.6%-2.7pp
Operating margin-30.8%-49.9pp
Net margin-39.2%-168pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-45.9%-94.9pp
Debt / equity1.9×+0.7×
Current ratio1.4×+0.3×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The source filing: QuidelOrtho Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0001906324-26-000033
Line itemJune 28, 2026December 28, 2025
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$236.5$279.4
Accrued payroll and related expenses76.8120.3
Income tax payable14.011.5
Current portion of borrowings355.7178.3
Other current liabilities310.4376.6
Total current liabilities993.4966.1

Item 1. Financial Statements (unaudited)

FAQ

What is QuidelOrtho Corporation's accrued expenses?
QuidelOrtho Corporation (QDEL) reported accrued expenses of $76.8M in Q2 2026.
How has QuidelOrtho Corporation's accrued expenses changed year-over-year?
QuidelOrtho Corporation's accrued expenses decreased by 9.1% year-over-year, from $84.5M to $76.8M.
What is the long-term trend for QuidelOrtho Corporation's accrued expenses?
Over 4 years (2021 to 2025), QuidelOrtho Corporation's accrued expenses has grown at a 31.4% compound annual growth rate (CAGR), from $40.4M to $120.3M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about QuidelOrtho Corporation's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude